nonaptbpd
n
group
lung
morpholog
number
lobar
segment
distribut
evalu
use
cxr
hrct
multivari
analysi
perform
identifi
independ
variabl
associ
use
gener
predict
score
model
predict
model
valid
separ
popul
patient
n
isnpd
ali
valid
model
hrct
cxr
hypoalbuminemia
sensit
specif
neg
predict
valu
isnaptb
posttest
probabl
deriv
cohort
preval
valid
cohort
preval
given
preval
preval
respect
hrct
model
effect
identifi
isnaptb
subject
among
isnpd
ali
regardless
cm
nonaptbpd
also
correctli
classifi
hrct
cxr
hypoalbuminemia
model
tuberculosi
tb
major
health
problem
around
world
earli
diagnosi
critic
control
tb
although
tb
affect
multipl
organ
primarili
involv
respiratori
system
highli
contagi
activ
pulmonari
tb
aptb
commonli
present
vagu
clinic
symptom
fever
weight
loss
chronic
product
cough
occasion
dyspnea
hemoptysi
sign
mistaken
communityacquir
pneumonia
miss
initi
diagnosi
emerg
depart
therebi
increas
risk
nosocomi
infect
addit
transmiss
diseas
gener
popul
acidfast
bacilli
afb
smear
respiratori
sputum
use
rapid
diagnosi
aptb
howev
test
note
poor
sensit
center
diseas
control
prevent
cdc
recommend
nucleic
acid
amplif
naa
includ
polymeras
chain
reaction
pcr
perform
least
one
respiratori
specimen
patient
sign
symptom
pulmonari
tb
diagnosi
tb
consid
yet
establish
howev
sensit
pcr
variabl
ie
sensit
smearneg
sn
poor
eg
routin
implement
pcr
first
specimen
submit
mycobacteri
cultur
without
consider
clinic
histori
impract
costli
result
pcr
may
avail
within
day
take
respiratori
specimen
howev
rapid
pcrbase
assess
depend
upon
abil
obtain
respiratori
specimen
therefor
initi
sputum
neg
one
day
may
need
obtain
anoth
sampl
subsequ
smearposit
sp
sputum
use
pcr
patient
andor
famili
member
may
refus
hesit
receiv
bronchoscopi
procedur
thu
specimen
obtain
way
recent
report
suggest
highresolut
comput
tomographi
hrct
may
use
tool
identifi
ptb
pneumonia
may
perform
bronchoscopi
especi
patient
bronchoscopi
perform
patient
tendenc
bleed
hrct
use
classifi
infecti
patient
ptb
patient
isol
hrct
play
import
role
identif
sever
acut
respiratori
syndrom
sar
addit
bronchoscopi
also
limit
necess
wait
result
cultur
particularli
smearfrom
bronchoscopi
specimen
common
reason
admit
aptb
patient
intens
care
unit
icu
develop
acut
lung
injuri
ali
acut
respiratori
distress
syndrom
ard
sever
organ
failur
acut
respiratori
failur
due
aptb
often
necessit
mechan
ventil
associ
mortal
rate
approxim
use
chestxray
cxr
comput
tomographi
ct
investig
determin
effect
diagnosi
aptb
icu
patient
case
control
studi
found
cxr
predict
aptb
significantli
contribut
diagnosi
aptb
icu
one
studi
found
extent
diseas
determin
hrct
correl
posit
smear
prior
studi
also
found
hrct
high
sensit
specif
predict
presenc
spaptb
howev
accuraci
hrct
cxr
patient
ali
eg
ard
diagnos
initi
smearneg
activ
pulmonari
tuberculosi
isnaptb
earli
stage
ali
well
understood
prior
studi
use
cxr
symptomssign
identifi
patient
snaptb
aptb
aim
current
studi
assess
diagnost
accuraci
cxrhrct
clinic
manifest
detect
isnaptb
classifi
nonaptbpd
among
patient
earli
stage
ali
isnpulmonari
diseas
isnpd
icu
admiss
within
hour
icu
admiss
deriv
cohort
patient
demograph
clinic
characterist
studi
includ
patient
ali
predict
isnaptb
n
nonaptbpd
n
tabl
mean
age
group
year
respect
male
compris
patient
group
respect
clinic
characterist
similar
group
includ
age
sex
previou
tb
diabet
mellitu
dm
steroid
use
chronic
obstruct
pulmonari
diseas
copd
liver
cirrhosi
uremia
upper
gastrointestin
bleed
lymphopenia
neutropenia
level
white
blood
cell
clinic
sign
symptom
group
significantli
higher
percentag
copd
hypoalbuminemia
compar
group
p
patient
group
also
significantli
higher
ali
score
apach
score
antecibum
ac
sugar
aspart
transaminas
got
alanin
transaminas
gpt
blood
urea
nitrogen
bun
creatinin
lower
level
hemoglobin
albumin
pao
f
sodium
compar
group
p
tabl
imag
result
cxr
result
indic
frequenc
consolidationpatchnodul
rightleft
upper
lung
field
higher
patient
patient
vs
p
valu
fig
cavit
rightleft
upper
lower
lung
field
also
preval
patient
patient
upper
vs
p
lower
vs
p
tabl
among
hrct
morpholog
find
frequenc
consolid
superior
segment
right
lower
lobeleft
lower
lobe
rlllll
greater
patient
patient
vs
p
tabl
frequenc
cluster
nodulesmass
cavit
region
lung
analyz
greater
patient
compar
patient
p
frequenc
militaryreticular
nodul
vs
p
pleural
effus
greater
patient
patient
vs
p
tabl
multivari
analysi
perform
identifi
independ
variabl
may
predict
isnaptb
includ
variabl
identifi
underli
diseas
symptomsign
cxr
underli
diseas
symptomssign
hrct
significantli
differ
group
p
statist
signific
p
percentag
tabl
analysi
use
find
underli
diseas
symptomssign
cxr
found
consolidationpatchnodul
rightleft
upper
lung
field
hypoalbuminemia
independ
variabl
isnaptb
p
hypoalbuminemia
cxr
model
tabl
multivari
analysi
underli
diseas
symptomssign
hrct
indic
cluster
nodulesmass
rullul
consolid
rlllll
independ
variabl
isnaptb
p
hrct
model
tabl
diagnost
model
evalu
diagnost
accuraci
set
rel
score
prior
multivari
analysi
p
valu
variabl
symptomssign
tabl
eg
age
sex
fever
cough
week
dyspnea
bodi
weight
loss
weak
hrct
eg
consolid
segment
lobe
except
treeinbud
centrilobular
nodul
bronchial
thicken
groundglass
opac
cxr
morpholog
eg
consolidationpatchnodul
rightleft
lower
lung
field
consolid
frequenc
variabl
wwwnaturecomscientificreport
wwwnaturecomscientificreport
lung
cancer
metastat
cancer
lung
n
nontuberculosi
mycobacterium
n
cryptococcosi
n
pneumonia
n
lung
diseas
n
pulmonari
edema
n
sarcoidosi
n
hypersens
pneumomn
n
smearposit
aptb
afb
sputum
smear
posit
acid
fast
bacilli
afb
sputum
smear
posit
afb
smearposit
chest
xray
consist
aptb
determin
treat
medic
offic
sputum
specimen
posit
afb
cultur
posit
afb
smearneg
aptb
afb
symptom
suggest
aptb
neg
cxr
consist
aptb
determin
medic
offici
follow
decis
treat
patient
full
cours
antituberculosi
therapi
diagnosi
base
posit
cultur
neg
afb
sputum
ac
ant
cibum
cr
creatinin
bun
blood
urea
nitrogen
got
aspart
transaminas
test
gpt
alanin
transaminas
test
initi
smearneg
activ
pulmonari
tuberculosi
isnaptb
nonaptb
pulmonari
diseas
nonaptbpd
dm
diabet
mellitu
wbc
white
blood
cell
dm
diabet
mellitu
copd
chronic
obstruct
pulmonari
diseas
bmi
bodi
mass
index
weight
kg
height
wwwnaturecomscientificreport
wwwnaturecomscientificreport
hrct
eg
cavit
segment
lobe
cluster
nodulesmass
segment
lobe
except
rightleft
upper
lobe
pleural
effus
cxr
morpholog
eg
cavit
rightleft
upper
lower
lung
field
militari
nodul
tabl
also
set
rel
score
tabl
multivari
analysi
found
hypoalbuminemia
cxr
model
estim
valu
consolidationpatchnodul
rightleft
upper
lung
field
hypoalbuminemia
sinc
estim
valu
greater
less
rel
score
set
tabl
multivari
analysi
hrct
model
found
estim
valu
consolid
rlllll
uppermiddl
lung
field
greater
less
estim
henc
rel
score
set
tabl
rel
score
rullul
cluster
nodulesmass
uppermiddl
lung
field
set
estim
valu
greater
estim
valu
tabl
lesion
uppermiddl
lung
field
rare
affect
respiratori
effect
variabl
hypoalbuminemia
cxr
model
variabl
copd
p
valu
hrct
model
variabl
copd
hypoalbuminemia
p
valu
reveal
set
tabl
variabl
underli
diseas
symptomsign
cxr
underli
diseas
symptomsign
hrct
model
reveal
set
tabl
current
model
differ
model
prior
studi
least
way
includ
clinic
manifest
analysi
previou
model
present
studi
set
valu
rel
score
estim
valu
estim
valu
given
rel
score
prior
studi
divid
larger
estim
valu
smallest
estim
valu
obtain
rel
score
score
present
studi
simpler
easier
use
confound
use
bronchiectasi
predictor
may
due
artifact
pseudobronchiectasi
moreov
present
studi
owe
fact
icu
critic
sourc
sever
nosocomi
infect
enrol
patient
ideal
cutoff
point
score
sensit
specif
identifi
isnaptb
cxr
hypoalbuminemia
respect
deriv
cohort
tabl
valid
cohort
tabl
posit
predict
valu
ppv
neg
predict
valu
cxr
hypoalbuminemia
respect
deriv
cohort
tabl
valid
cohort
tabl
auc
valu
roc
curv
hrct
model
deriv
cohort
valid
cohort
ci
ci
p
ideal
cutoff
point
score
sensit
specif
identifi
isnaptb
hrct
respect
deriv
cohort
valid
cohort
tabl
posit
predict
valu
npv
deriv
cohort
respect
valid
cohort
tabl
posttest
probabl
deriv
cohort
preval
valid
cohort
preval
given
preval
preval
respect
rel
score
cxr
includ
radiologist
radiologist
radiologist
hrct
cxr
hypoalbuminemia
summar
supplementari
tabl
distribut
patient
score
radiologist
vs
radiologist
hrct
cxr
deriv
cohort
present
supplementari
tabl
actual
time
arteri
blood
ga
pf
ratio
mmhg
bilater
infiltr
chestxray
hrct
show
supplementari
tabl
earli
prompt
diagnosi
isnaptb
import
treat
affect
patient
inhibit
spread
diseas
divers
clinic
present
patient
isnaptb
possibl
limit
healthcar
resourc
particularli
influenza
outbreak
may
complic
effect
manag
isnaptb
present
studi
design
identifi
independ
diseaserel
variabl
associ
symptomssign
cxr
wwwnaturecomscientificreport
wwwnaturecomscientificreport
accuraci
identifi
patient
isnaptb
valid
model
develop
deriv
cohort
studi
found
hrct
high
sensit
higher
sensit
may
help
clinician
evalu
therapeut
respons
antituberculosi
drug
within
hour
find
indic
hrct
good
diagnost
accuraci
identifi
isnaptb
icu
patient
ali
benefit
hrct
smear
cultur
test
afb
among
icu
patient
isnaptb
fact
result
avail
within
singl
day
hrct
allow
initi
antitb
treatment
cultur
pcr
result
avail
especi
use
patient
consist
previou
studi
although
current
model
replac
need
cultur
evalu
pcr
result
diagnosi
isnaptb
often
delay
wait
cultur
result
diagnosi
often
made
base
cxr
clinic
respons
result
empir
antitb
treatment
without
microbiolog
confirm
result
studi
highlight
hrct
model
demonstr
use
method
patient
ali
without
signific
differ
symptomssign
isnaptb
nonaptbpd
respiratori
specimen
unavail
cxr
reveal
atyp
present
thu
model
may
help
clinician
tri
antitb
drug
monitor
therapeut
respons
patient
score
wait
final
tb
cultur
pcr
result
initi
sputum
assess
neg
recent
studi
found
concomit
bacteri
ptb
infect
uncommon
frequenc
present
studi
exclud
patient
concurr
bacteria
plu
ptb
deriv
n
valid
cohort
n
isp
phase
patient
receiv
antibiot
prior
receiv
afb
result
afb
result
known
patient
treat
antitb
antibiot
bacteri
aptb
present
patient
deriv
n
valid
n
cohort
bacteri
infect
treat
antibiot
ct
angiogram
sign
consolid
may
help
differenti
malign
lesion
benign
lesion
howev
present
studi
enhanc
consolid
lesion
contrast
medium
routin
owe
poor
renal
function
typic
ali
tabl
even
benign
lesion
ptb
rlllll
higher
frequenc
malign
lesion
malign
lesion
may
present
consolid
rlllll
score
may
confound
result
final
use
differ
milliamperag
set
perform
previous
therefor
imag
qualiti
score
repeat
scan
obtain
tabl
also
set
rel
score
cxr
chest
xray
wwwnaturecomscientificreport
wwwnaturecomscientificreport
cohort
unavail
owe
critic
condit
patient
use
interobserv
total
score
replac
imag
qualiti
score
show
good
result
kappa
valu
model
uppermiddl
lung
field
includ
hypoalbuminemia
cxrrullul
consolidationpatchnodul
model
hrct
model
rullul
cluster
nodulesmass
consolid
rlllll
use
idea
attenu
confound
factor
cardiacrespiratori
artifact
howev
whether
use
imag
qualiti
score
ali
patient
warrant
investig
sever
aptb
icu
critic
sourc
nosocomi
infect
ct
chest
scan
may
help
gather
diagnost
inform
ali
patient
tb
suspect
confirm
also
allow
target
use
bronchoscopi
ctguid
biopsi
januari
juli
new
valid
model
isnaptb
concomit
bacteria
likelihood
base
hrct
score
supplementari
tabl
give
preval
posttest
probabl
optim
level
cutoff
wwwnaturecomscientificreport
wwwnaturecomscientificreport
threshold
isol
describ
previous
therefor
model
potenti
identifi
cohort
high
lower
preval
rang
nevertheless
result
warrant
addit
studi
sever
limit
consid
interpret
find
present
studi
first
analysi
limit
variabl
evalu
use
cxr
hypoalbuminemia
hrct
model
possibl
clinic
variabl
may
also
predict
isnaptb
addit
patient
popul
drawn
limit
geograph
region
known
find
may
translat
region
addit
studi
requir
countri
popul
valid
model
order
patient
receiv
hrct
invas
mechan
ventil
n
deriv
cohort
n
valid
cohort
necessari
physician
callavail
usual
taiwan
hospit
emerg
room
er
close
ct
room
transport
time
within
minut
nearli
patient
er
staf
experienc
emerg
doctor
duti
hour
day
meanwhil
larg
portion
patient
deriv
valid
cohort
receiv
hrct
er
without
invas
mechan
ventilationonli
receiv
hrct
invas
mechan
ventil
icu
patient
receiv
invas
mechan
ventil
sedat
use
sed
drug
may
associ
aspir
pneumonia
shock
hypoxemia
howev
hrct
perform
earli
possibl
studi
unexpect
advers
reaction
may
avoid
mortal
rare
found
transport
process
patient
earli
ali
previou
report
mortal
found
transport
process
among
patient
present
studi
conclus
find
support
use
hrct
identif
isnaptb
trial
antibacteri
treatment
isol
polic
meanwhil
unavail
area
hrct
model
npv
deriv
cohort
cxr
hypoalbuminemia
model
npv
deriv
cohort
abil
correctli
classifi
nonaptbpd
thu
simpl
model
may
avoid
overus
isol
room
final
owe
high
likelihood
ratio
deriv
cohort
posttest
probabl
lower
preval
therefor
model
may
use
area
may
altern
choic
auxiliari
role
bronchoscopi
among
patient
especi
sputumsmear
statu
consequ
still
need
wait
cultur
result
sputumsmear
statu
although
addit
studi
need
address
issu
method
ethic
consider
present
studi
perform
accord
declar
helsinki
ethic
committe
pingtung
christian
hospit
approv
studi
protocol
patient
receiv
hrct
provid
sign
inform
consent
particip
studi
studi
design
patient
popul
retrospect
studi
enrol
patient
pulmonari
diseas
ali
receiv
cxr
examin
march
decemb
pingtung
christian
hospit
branch
patient
admit
intens
care
unit
icu
ptb
high
risk
hospit
nosocomi
infect
patient
immun
impair
associ
immunocompromis
factor
eg
age
year
copd
dm
uremia
liver
cirrhosi
steroid
use
lymphopenia
neutropenia
lower
tabl
sensit
specif
posit
predict
valu
neg
predict
valu
hrct
cxr
plu
hypoalbuminemia
model
valid
cohort
n
cxr
chest
xray
fals
posit
rate
fals
neg
rate
initi
smearneg
activ
pulmonari
tuberculosi
wwwnaturecomscientificreport
wwwnaturecomscientificreport
bodi
mass
index
hypoalbuminemia
predispos
patient
aptb
therefor
aptb
suspect
among
patient
base
sign
symptom
time
clinic
present
tabl
consequ
patient
receiv
set
acid
fast
bacilli
examin
tb
cultur
cxr
patient
exclud
hrct
n
author
duti
time
examin
patient
also
exclud
result
indic
artifact
procedur
artifact
n
includ
motion
artifact
heart
n
respiratori
artifact
n
pulsat
star
artifact
n
patient
also
exclud
initi
sputum
smear
posit
isp
afb
n
aptb
ispaptb
cardiac
motion
artifact
sometim
interf
accur
evalu
extent
area
groundglass
attenu
due
predomin
distribut
lower
lobe
includ
pericardiac
area
remain
patient
n
initi
smearneg
pulmonari
diseas
isnpd
includ
supplementari
fig
confirm
diagnosi
patient
divid
two
group
diagnosi
ali
includ
follow
acut
hypoxia
ratio
partial
pressur
arteri
oxygen
fraction
inspir
oxygen
pao
f
mmhg
without
elev
arteri
paco
presenc
bilater
infiltr
seen
cxr
evid
left
atrial
hypertens
manag
ali
consist
oxygen
therapi
includ
patient
receiv
hrct
er
receiv
hrct
admit
icu
deriv
cohort
supplementari
tabl
patient
receiv
hrct
within
hour
diagnosi
ali
patient
transport
er
icu
ou
ct
hrct
valid
cohort
patient
final
confirm
diagnosi
admiss
icu
diagnost
model
see
statist
analysi
deriv
deriv
phase
studi
test
diagnost
accuraci
patient
enrol
januari
decemb
pulmonari
diseas
ali
n
total
patient
immun
impair
associ
immunocompromis
factor
deriv
cohort
patient
receiv
set
tb
smear
cultur
cxr
patient
exclud
ali
initi
sputum
smear
posit
isp
afb
n
aptb
patient
without
hrct
n
author
duti
time
examin
artifact
procedur
n
includ
cohort
motion
artifact
heart
n
respiratori
artifact
n
pulsat
star
artifact
n
remain
isnpd
patient
enrol
valid
cohort
supplementari
fig
patient
wait
nd
rd
smearposit
sputum
hrct
perform
within
hour
includ
patient
receiv
hrct
er
receiv
hrct
icu
supplementari
tabl
patient
receiv
hrct
within
hour
diagnosi
ali
transport
patient
er
icu
ct
hrct
test
abil
model
hrctcxr
underli
diseas
clinic
symptomsign
detect
isnaptb
classifi
nonaptbpd
among
enrol
patient
apach
ii
score
ali
score
acut
physiolog
age
chronic
health
evalu
apach
ii
score
prognost
score
system
diseas
sever
critic
ill
patient
icu
variabl
use
calcul
apach
ii
score
includ
blood
pressur
heart
rate
respiratori
rate
bodi
temperatur
serum
level
sodium
serum
level
potassium
serum
level
creatinin
arteri
ph
alveolararteri
oxygen
gradient
hematocrit
white
blood
cell
count
score
glasgow
coma
scale
apach
ii
score
calcul
sum
weight
point
repres
extent
physiolog
derang
acut
physiolog
score
point
base
patient
age
chronic
ill
worst
acut
physiolog
score
record
initi
hour
icu
stay
use
apach
ii
score
patient
determin
time
admiss
icu
nurs
train
use
instrument
ali
score
includ
cxr
evalu
alveolar
consolid
pao
f
posit
end
expiratori
pressur
peep
level
ventil
respiratori
complianc
known
polymeras
chain
reaction
pcr
roch
amplicor
mycobacterium
test
amplicor
mtb
roch
diagnost
system
somervil
nj
usa
detect
tuberculosi
bacilli
smearposit
specimen
first
set
sputum
neg
result
test
spontan
sputum
collect
spontan
sputum
unavail
day
sputum
obtain
bronchoscopi
invas
airway
eg
intub
airway
time
result
pcr
tb
cultur
reveal
tabl
hematolog
biochem
data
blood
cultur
appropri
cultur
specimen
infect
obtain
hematolog
biochem
data
also
collect
systemat
day
er
admiss
white
blood
count
lymphocyt
count
neutrophil
count
hemoglobin
measur
use
standard
commerci
kit
sysmex
sysmex
corpor
japan
perform
use
sysmex
ant
cibum
ac
blood
urea
nitrogen
bun
creatinin
cr
albumin
aspart
transaminas
got
alanin
wwwnaturecomscientificreport
wwwnaturecomscientificreport
transaminas
gpt
concentr
measur
subject
use
standard
method
perform
unicel
dxc
analyz
beckman
coulter
inc
usa
arteri
blood
ga
analysi
blood
sampl
drawn
place
ice
immedi
transmit
laboratori
analysi
blood
ga
analyz
phox
plu
blood
ga
analyz
nova
biomed
waltham
usa
accuraci
analyz
valid
daili
accord
standard
qualiti
assur
protocol
evalu
chest
xray
high
resolut
comput
tomographi
cxr
anteroposterior
posteroanterior
later
hrct
imag
thorac
lesion
perform
admiss
retrospect
evalu
within
day
day
imag
collect
patient
deriv
valid
cohort
cxr
hrct
evalu
three
radiologist
year
experi
two
chest
physician
one
year
experi
five
year
experi
type
imag
evalu
simultan
radiologist
could
refer
compar
final
decis
imag
result
reach
consensu
within
hour
interobserv
intraobserv
agreement
cxr
hrct
show
high
cohen
kappa
valu
cxr
pattern
parenchym
lesion
seen
cxr
classifi
airspac
consolidationpatch
small
nodulesreticular
lesion
andor
cavit
lung
divid
region
analysi
lesion
design
rightleft
upper
lung
field
rightleft
lower
lung
field
previous
describ
high
resolut
comput
tomographi
figur
supplementari
fig
high
resolut
ct
scan
perform
use
scanner
brillianc
philip
medic
system
cleveland
oh
usa
set
mm
collim
kv
ma
tabl
speed
mmsec
rotat
time
sec
pitch
imag
acquir
singl
breathhold
last
five
eight
second
nasal
cannula
n
mask
oxygen
invas
ventil
support
n
tri
mask
noninvas
ventil
set
n
earli
stage
ali
among
patient
spontan
breath
patient
without
spontan
breath
imag
acquir
end
phase
inspir
n
portabl
invas
ventil
set
respiratori
motion
greatest
lung
base
scan
caudaltocrani
direct
may
help
minim
respiratori
artifact
scan
lung
base
acquir
patient
hold
breath
howev
method
render
respiratori
motion
artifact
uncommon
patient
imag
reconstruct
slice
thick
axial
plane
gap
coron
plane
apart
use
high
spatialfrequ
algorithm
subsequ
sent
pictur
archiv
commun
system
pac
review
thinsect
mdct
imag
display
monitor
pulmonari
window
level
set
level
hu
width
hu
hrct
analysi
lung
divid
segment
see
tabl
footnot
hrct
morpholog
includ
consolid
lobar
segment
subseg
lobular
cavit
cluster
nodulesmass
branch
centrilobular
nodular
lesion
ie
treeinbud
pattern
centrilobular
nodul
reticular
nodul
interlobular
thicken
groundglass
opac
pleural
effus
analyz
peripher
distribut
consolid
cavit
cluster
nodulesmass
distribut
also
analyz
find
reach
consensu
kappa
valu
cxr
hrct
morpholog
read
result
statist
analysi
data
present
mean
standard
deviat
sd
continu
variabl
number
percentag
categor
variabl
twosampl
ttest
use
compar
differ
group
continu
data
pearson
chisquar
test
fisher
exact
test
use
compar
differ
distribut
categor
data
group
multipl
logist
regress
analysi
perform
indic
predictor
subject
isnaptb
estim
beta
standard
error
odd
ratio
confid
interv
ci
determin
rel
score
use
predict
model
given
differ
independ
variabl
use
estim
base
describ
section
diagnost
model
evalu
diagnost
accuraci
statist
analys
consid
signific
p
also
test
abil
model
use
posttest
probabl
two
phase
given
preval
statist
analys
perform
use
spss
statist
softwar
spss
inc
chicago
il
usa
data
present
manuscript
readili
avail
